Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -13.04M
March 31, 2026 -3.439M
December 31, 2025 -3.647M
September 30, 2025 -0.9709M
June 30, 2025 -0.6749M
March 31, 2025 -0.9481M
December 31, 2024 -11.80M
September 30, 2024 -1.895M
June 30, 2024 -7.686M
March 31, 2024 5.760M
December 31, 2023 -4.101M
September 30, 2023 -3.434M
June 30, 2023 -4.189M
March 31, 2023 -4.071M
December 31, 2022 -3.986M
September 30, 2022 4.391M
June 30, 2022 -5.408M
March 31, 2022 -9.627M
December 31, 2021 -11.17M
September 30, 2021 -30.40M
June 30, 2021 -9.279M
March 31, 2021 -7.686M
December 31, 2020 -17.40M
Date Value
September 30, 2020 -5.314M
June 30, 2020 -4.696M
March 31, 2020 -5.261M
December 31, 2019 -1.282M
September 30, 2019 -4.192M
June 30, 2019 -5.043M
March 31, 2019 -4.661M
December 31, 2018 -4.020M
September 30, 2018 -2.572M
June 30, 2018 -3.309M
March 31, 2018 -3.633M
December 31, 2017 -2.481M
September 30, 2017 -3.134M
June 30, 2017 -2.672M
March 31, 2017 -2.809M
December 31, 2016 -5.632M
September 30, 2016 -3.198M
June 30, 2016 -3.771M
March 31, 2016 -1.991M
December 31, 2015 -0.6662M
September 30, 2015 -1.874M
June 30, 2015 -2.199M
March 31, 2015 -1.191M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 53.52M
Alnylam Pharmaceuticals, Inc. 2.167B
Anika Therapeutics, Inc. 3.309M
Savara, Inc. -40.23M
Vericel Corp. 2.206M